What's new

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised

Feb 20, 2025 - 10:22
 0
Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

HBX Group and Minor Hotels expand strategic partnership to include hotels in Aus...

Next Article

Switzerland’s Haelixa appoints Marwa Zamaray to advisory board

Related Posts

PSUSA/00009236/202406

PSUSA/00009236/202406

Feb 13, 2025  0

Product Management Service (PMS) webinar : Unlocking Integration – MAH & Software Developers to explore PMS API Machine-to-Machine Connection, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 March 2025, 10:00 (CET) to 14 March 2025, 12:00 (CET)

Product Management Service (PMS) webinar : Unlocking In...

Mar 18, 2025  0

EMEA-002744-PIP01-19-M01

EMEA-002744-PIP01-19-M01

Mar 25, 2025  0